Bintrafusp alfa (BA) is a fusion protein that concurrently inhibits two immunosuppressive pathways, TGF-β pathway and programmed death-ligand 1 (PD-L1) pathway, potentially impeding cancer cell proliferation by blocking TGF-β signaling [190]. This evidence concerns the gene TGFB1 and cancer.